
U203-E Display
This device is mainly applied in the system of dispenser to remove the solid sedimentation is the oil ,ensuring the cleaning of the oil or like ,and as a result to extend the life span and accuracy of the flow meter. In the system of dispenser ,it is fixed between the oil pump and the flow meter.
Materials:
Body: Body: Aluminum (Spray-Painted)
Seals: Buna-N
Technical Specifications:
Working pressure:0.2Mpa
Filter accuracy:30um
Flow Rate:65L/min
Rating Medium:Gasoline,Kerosene, Diesel
100% Factory Tested.
Package:
Product ID Net Weight Cross Weight Dimension
U103-A 2kg/case of1 2.2kg/case of1 20x13x14cm/case of1
we are committed to create the best workplace, encourage our staffs to put their own personalities into their jobs, and provide them a stage to show themselves.
ter the market.
Money will not be showered on a company the moment it crosses the finish line, but will be paid out a little at a
time. In one scenario, the final customers for vaccines would set the pace. For example, the Kenyan health
ministry would decide whether to buy a company s vaccine, for $1 per dose, and the company would then receive a
“top-up�payment of $14 from the G8. If the pot (including the Kenyan co-payments) contained $3 billion, it would
be drained only after 200m shots had been sold. This, advocates hope, will give a second-generation vaccine time
to steal the market from its forerunners.
fuel dispenser
Unfortunately, this set-up creates problems of its own. Corruption is one danger. If every dollar that a health
ministry spends on a given vaccine is worth another $14 to the company supplying it, an unscrupulous firm might
go to illegal lengths to attract the ministry s custom.
A cure fuel dispenser or a placebo?
What if companies fail to bite at the carrot the G8 dangles before them, or fall short of a vaccine donors are willing
to buy? Well then, argues Mr Kremer, donors have lost nothing. If his scheme fails, the public purse has lost hardly
a cent. If it succeeds, then every dollar spent is eminently worthwhile. This, needless to say, is a big part of his
scheme s appeal to politicians.
But Mr Farlow doubts that a G8 promise would be credible unless funds were set aside in advance—money he
would rather were used elsewhere. There is much else to spend it on. By one count, more than 25 malaria vaccines
are currently in or near clinical trials, pushed by public money and philanthropic generosity. Several vaccines, for
example against hepatitis B, have already been invented, but fail to reach all the poor.
APCs should not stop governments providing a push wherever it is needed, Mr Kremer insists. But will governments
themselves hear him? Critics argue that even if his scheme makes no claim on public funds today, it has still made
a big demand on political attention, diverting it from fuel dispenser